Clinical Trial Update: APART Advanced Profiling of Anti-Rheumatic Therapies [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for anti-rheumatic therapies (APART study) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis Rheumatoid

Snippet

Sponsor: Centocor Ortho Biotech Services, L.L.C. | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED